In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Teligent Inc.

www.teligent.com

Latest From Teligent Inc.

People Round-Up: Endo Promotes Ciarico To Head Steriles And Generics

Endo has named a head for its sterile injectables and generics operations; Hikma has appointed an R&D head; Acino has a new leader for its Latin American business; Alvogen has appointed a general counsel; and Julphar has shaken up its senior management team.

 
Appointments Leadership

Teligent Targets Smaller Customers As It Seeks Sustainable Margins

Focusing more on smaller sales channels, as well as culling less lucrative lines, are two key strategies Teligent is employing as it seeks to raise profit margins to levels that will allow the US niche generics player to avoid breaching its debt covenants.

 

Business Strategies Sales & Earnings

Teligent Has No Explanation For Sudden Share-Price Slide

US niche generics specialist Teligent is at a loss to explain why its share price has tumbled in recent times as it ramps up production at an expanded injectables facility.


Finance Watch: Alphamab's $100m Series A Continues Theme Of Big Investments In China Biopharma

The Suzhou-based drug developer brings in new cash as US venture deals take a holiday. Also, France's Genfit may go public in the US, Taiwan Liposome launches its IPO, and Bioblast's strategic review ends in a reverse merger.

Financing StartUps and SMEs
See All

Company Information

  • Industry
  • Contract Research, Toxicology Testing-CRO
  • Pharmaceuticals
    • Drug Delivery
      • Topical Delivery
    • Generic Drugs
    • OTC, Consumer
  • Services
  • Therapeutic Areas
  • Infectious & Viral Diseases
  • Inflammation
  • Alias(es)
  • IGI Inc.
  • IGI Laboratories Inc.
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Teligent Inc.
  • Senior Management
  • Jason E Grenfell-Gardner, Pres. & CEO
    Damian Finio, CFO
    Peter Gallagher, VP, Scientific Affairs
    Steve Richardson, CSO
    Barbara Lani, SVP, Quality
    Eric Muse, VP, BD
  • Contact Info
  • Teligent Inc.
    Phone: (856) 697-1441
    105 Lincoln Ave.
    Buena, NJ 08310
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register